biostudies-literatureUnknown23(9)Pereira MP<h4>Background and objectives</h4>Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline-recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population.<h4>Patients and methods</h4>The Global Allergy and Asthma Excellence Network (GA²LEN) ADCARE initiative collected data from physicians worldwide who treat pregnant women with AD. Physicians completed an electronic questionnaire on the use of systemic agents in pregnant/breastfeeding AD patients.<h4>Results</h4>103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). AntihistaminJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG1116-1124https://www.ebi.ac.uk/biostudies/studies/S-EPMC12435135biostudies-literatureInternational survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.PMC12435135Meesch CChu CYZuberbier TZhao ZWerfel TEnsina LFOzkaya ECork MKatoh NKocaturk EKulthanan KParisi CASStevanovic KWollenberg APereira MPPerez CRGregoriou SBruscky DGimenez-Arnau AMRamon GNGodse KVakirlis EChong-Neto HJPudasaini PWorm MMitrevska NTvan Hofman IFelix MMRCriado RFJBeck LAGotua MVaswani PSBernstein JAde Bruin-Weller MMortz CGfalseInternational survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.<h4>Background and objectives</h4>Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline-recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population.<h4>Patients and methods</h4>The Global Allergy and Asthma Excellence Network (GA²LEN) ADCARE initiative collected data from physicians worldwide who treat pregnant women with AD. Physicians completed an electronic questionnaire on the use of systemic agents in pregnant/breastfeeding AD patients.<h4>Results</h4>103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). Antihistamin2025-01-01T00:00:00Z2025 Sep2026-04-08T19:52:31.06Z2026-04-08T14:35:51.582ZS-EPMC124351354048481010.1111/ddg.15728